VOLUVEN

This brand name is authorized in Australia, Austria, Canada, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Tunisia.

Active ingredients

The drug VOLUVEN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 1GVO236S58 - HYDROXYETHYL STARCH 130/0.4
 
Read more about HAES
2
UNII 451W47IQ8X - SODIUM CHLORIDE
 

Sodium chloride is the principle salt involved in maintaining the osmotic tension of blood and tissues. Changes in osmotic tension influence the movement of fluids and diffusion of salts in cellular tissue.

 
Read more about Sodium chloride

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A12CA01 Sodium chloride A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CA Sodium
Discover more medicines within A12CA01
B05AA07 Hydroxyethylstarch B Blood and blood forming organs → B05 Blood substitutes and perfusion solutions → B05A Blood and related products → B05AA Blood substitutes and plasma protein fractions
Discover more medicines within B05AA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 9487H
CA Health Products and Food Branch 02278057
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 30112-02-12
EE Ravimiamet 1111172, 1111194, 1111206, 1111475, 1111486, 1262258, 1262269, 1262281, 1311310, 1311321, 1311332
ES Centro de información online de medicamentos de la AEMPS 64001
FI Lääkealan turvallisuus- ja kehittämiskeskus 001881, 066287
FR Base de données publique des médicaments 67941758
HK Department of Health Drug Office 50474
JP 医薬品医療機器総合機構 3319408A1020
LT Valstybinė vaistų kontrolės tarnyba 1010360, 1010361, 1065697, 1065698, 1065699, 1065700, 1065701, 1065702, 1065703, 1065704, 1065705, 1065706, 1065707, 1065708, 1065709, 1065710, 1065711, 1065712
NL Z-Index G-Standaard 14580810
NL Z-Index G-Standaard, PRK 43826
NZ Medicines and Medical Devices Safety Authority 10568
PL Rejestru Produktów Leczniczych 100108622, 100231713
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W57705001, W57705002, W57705003, W57705004, W57705006, W57705007, W57705008, W57705009, W57705010, W57705011, W57705012, W57705013, W57705014, W57705015, W57705016, W57705017, W57705018
SG Health Sciences Authority 12297P
TN Direction de la Pharmacie et du Médicament 3153041H

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.